Mark Bond
Impact in
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
- NF-κB Signaling Pathways
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Papers in
-
- Signaling Pathways in Disease 7
- Ubiquitin and proteasome pathways 3
-
- Protease and Inhibitor Mechanisms 11
- NF-κB Signaling Pathways 5
- Co-authors
- Andrew C. Newby (29 shared papers)Andrew H. Baker (5 shared papers)Rosalind P. Fabunmi (1 shared paper)Graciela B. Sala‐Newby (18 shared papers)Gillian Murphy (3 shared papers)A.C. Newby (5 shared papers)Jian Qi (1 shared paper)Lena Claesson‐Welsh (1 shared paper)
- Journals
- Health Technology Assessment (8 papers)Journal of Molecular and Cellular Cardiology (6 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (4 papers)Journal of Biological Chemistry (4 papers)Cardiovascular Research (3 papers)
- Partner nations
- United KingdomUnited StatesTaiwan
In The Last Decade
Mark Bond
61 papers receiving 3.9k citations
Mark Bond's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.0k
- Immunology and Allergy 277
- Oncology 598
- Cell Biology 346
- Molecular Biology 1.4k
Countries citing papers authored by Mark Bond
This map shows the geographic impact of Mark Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bond more than expected).
Fields of papers citing papers by Mark Bond
This network shows the impact of papers produced by Mark Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bond. The network helps show where Mark Bond may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Hit paper breakdown → | 2003 | 556 |
| 2 | 1998 | 467 | |
| 3 | 2001 | 330 | |
| 4 | 2009 | 246 | |
| 5 | 2012 | 244 | |
| 6 | 1999 | 160 | |
| 7 | 2002 | 155 | |
| 8 | 2013 | 144 | |
| 9 | 2002 | 123 | |
| 10 | 2000 | 109 | |
| 11 | 2008 | 98 | |
| 12 | 2010 | 88 | |
| 13 | 2018 | 73 | |
| 14 | 2015 | 72 | |
| 15 | 2019 | 69 | |
| 16 | 2009 | 69 | |
| 17 | 2006 | 68 | |
| 18 | 2002 | 58 | |
| 19 | 2008 | 56 | |
| 20 | 2004 | 54 |
About Mark Bond
Mark Bond is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Immunology and Allergy and Cardiology and Cardiovascular Medicine, having authored 61 papers that have together received 3.9k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (11 papers), Hippo pathway signaling and YAP/TAZ (7 papers), Signaling Pathways in Disease (7 papers), Cell Adhesion Molecules Research (7 papers), NF-κB Signaling Pathways (5 papers), Hearing Loss and Rehabilitation (4 papers), Cellular Mechanics and Interactions (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Immunology and Allergy (277 citations), Oncology (598 citations), Cell Biology (346 citations) and Molecular Biology (1.4k citations). Mark Bond has collaborated with scholars based in United Kingdom, United States and Taiwan. Frequent co-authors include Andrew C. Newby, Andrew H. Baker, Rosalind P. Fabunmi, Graciela B. Sala‐Newby, Gillian Murphy, A.C. Newby, Jian Qi, Lena Claesson‐Welsh, Nina Z. Moore and Bela Anand‐Apte. Their work appears in journals such as Health Technology Assessment, Journal of Molecular and Cellular Cardiology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Journal of Biological Chemistry and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.